Medylex recently hosted an educational webinar featuring Dr. Marko Popovic, Medical Retina Specialist and Assistant Professor at the University of Toronto.
The session offered a practical, clinician-led overview of retinal vascular conditions - some of the most common causes of vision loss in adults - and how they are diagnosed, managed, and interpreted in clinical and Independent Medical Examination (IME) contexts.
For those who couldn’t attend live, here’s a recap of the key takeaways.
Dr. Popovic began with a foundational overview of eye anatomy, focusing on the retina, the light-sensitive tissue lining the back of the eye. The retina plays a critical role in converting light into electrical signals that the brain interprets as vision.
This distinction is especially important when assessing functional impact rather than assuming total vision loss.
Modern ophthalmology relies on a combination of clinical examination and advanced imaging. Dr. Popovic highlighted several key diagnostic tools commonly referenced in ophthalmology and IME reports:
These tools allow for objective measurement of disease severity, progression, and treatment response.
AMD is the leading cause of vision loss in adults over 50 in developed countries.
Dr. Popovic emphasized that while wet AMD can significantly affect central vision, timely treatment with anti-VEGF injections can dramatically improve outcomes, often restoring functional vision.
DME is the most common cause of vision loss in people with diabetes.
Sequential anti-VEGF treatment was shown to reduce retinal swelling and improve vision, reinforcing the importance of coordinated medical care.
RVO occurs when blood flow out of the retina is blocked, leading to swelling and hemorrhage.
Despite severe initial presentations, Dr. Popovic shared case examples where vision improved substantially with treatment, even in those approaching legal blindness.
Across all three conditions, anti-VEGF medications have transformed retinal care.
These therapies reduce abnormal blood vessel leakage, limit inflammation, and prevent harmful new vessel growth
Dr. Popovic noted that advancements in drug design now allow for longer treatment intervals reducing patient burden while improving outcomes.
During the Q&A, Dr. Popovic addressed retinal conditions most commonly encountered in IMEs, particularly in trauma-related cases.
Key points included:
This webinar reinforced the importance of specialist-led, evidence-based ophthalmology insight when retinal conditions are relevant to a claim. As Dr. Popovic demonstrated, modern retinal imaging and treatment outcomes allow for nuanced, objective interpretation of visual impairment, prognosis, and functional impact.
For insurers, legal professionals, and case managers, this level of clinical clarity is essential to informed decision-making - particularly in complex or high-stakes files involving vision loss, trauma, or systemic disease.
Medylex works with leading medical specialists, including Dr. Marko Popovic, to deliver timely, defensible ophthalmology assessments across Canada.
If you are managing a file involving retinal vascular disease, vision loss, or ophthalmic concerns and would like to discuss an assessment or referral:
Get in touch with the Medylex team to book an assessment with Dr. Popovic or to learn more about our independent ophthalmology assessment services.
Medylex. National Network. Local Insight. Trusted Results.